Cullinan Oncology
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
GADICKE ANSBERT
Common Stock 28,532 $29.04 $828,569
Sale
UBS ONCOLOGY IMPACT FUND L.P.
Common Stock 25,067 $29.04 $727,946
Sale
GADICKE ANSBERT
Common Stock 14,491 $29.6 $428,934
Sale
UBS ONCOLOGY IMPACT FUND L.P.
Common Stock 12,731 $29.6 $376,838
Sale
GADICKE ANSBERT
Common Stock 17,935 $29.46 $528,365
Sale
UBS ONCOLOGY IMPACT FUND L.P.
Common Stock 15,757 $29.46 $464,201
Sale
GADICKE ANSBERT
Common Stock 6,504 $29.47 $191,673
Sale
UBS ONCOLOGY IMPACT FUND L.P.
Common Stock 5,714 $29.47 $168,392
Sale
GADICKE ANSBERT
Common Stock 3,230 $29.79 $96,206
Sale
UBS ONCOLOGY IMPACT FUND L.P.
Common Stock 2,838 $29.79 $84,530
Sale
UBS ONCOLOGY IMPACT FUND L.P.
Common Stock 31,001 $29.3 $908,329
Sale
GADICKE ANSBERT
Common Stock 35,286 $29.3 $1,033,880
Sale
UBS ONCOLOGY IMPACT FUND L.P.
Common Stock 13,357 $29.09 $388,555
Sale
GADICKE ANSBERT
Common Stock 15,203 $29.09 $442,255
Sale
GADICKE ANSBERT
Common Stock 1,950 $29.09 $56,726
Sale
UBS ONCOLOGY IMPACT FUND L.P.
Common Stock 1,713 $29.09 $49,831
Sale
GADICKE ANSBERT
Common Stock 57,907 $29.48 $1,707,098
Sale
UBS ONCOLOGY IMPACT FUND L.P.
Common Stock 50,822 $29.48 $1,498,233
Sale
ZAWEL LEIGH
Common Stock 28,118 $29 $815,422
Sale
GADICKE ANSBERT
Common Stock 60,735 $29.11 $1,767,996
Sale
UBS ONCOLOGY IMPACT FUND L.P.
Common Stock 53,359 $29.11 $1,553,280
Option
MICHAELSON JENNIFER
Common Stock 4,000 $4.3 $17,200
Sale
MICHAELSON JENNIFER
Common Stock 4,000 $27.79 $111,140
Option
MICHAELSON JENNIFER
Stock Option (Right to Buy) 4,000 $4.3 $17,200
Sale
GADICKE ANSBERT
Common Stock 2,857 $29.05 $82,996
Sale
UBS ONCOLOGY IMPACT FUND L.P.
Common Stock 2,510 $29.05 $72,916
Sale
ZAWEL LEIGH
Common Stock 6,914 $27.44 $189,741
Sale
ZAWEL LEIGH
Common Stock 21,204 $26.82 $568,585
Purchase
HUGHES OWEN
Common Stock 2,500 $21 $52,500
Purchase
TRIGILIO JEFFREY
Common Stock 2,250 $21 $47,250
Purchase
JOVAN-EMBIRICOS MORANA
Common Stock 200,000 $21 $4,200,000
Purchase
GADICKE ANSBERT
Common Stock 300,000 $21 $6,300,000
Purchase
UBS ONCOLOGY IMPACT FUND L.P.
Common Stock 300,000 $21 $6,300,000

Showing 150 to 183 of 183 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: